Before I decided to found BARTH CONSULTING, I already gained many years of professional experience in the elaboration, negotiation and execution of contracts, including the definition of commercial frameworks, as well as monitoring of contracts, budgets and timelines. In addition, I offer profound knowledge in preparing contract templates.


I have worked in various pharmaceutical companies (consulting,  biotechnology companies, globally acting pharmaceutical companies) and have over ten years of experience in business development and licensing, contract management, international project and team management, strategic business development, in strategic marketing and sales controlling , as well as in market and competition analysis.



I am biologist and got my PhD at the University of Regensburg. Before I moved to industry I worked for the pharmaceutical biology department at Ludwig-Maximilians-University Munich as Head of a research group.







Bernhard Schmeilzl gained many years of experience as a legal advisor to several pharmaceutical and biotech companies as an in-house counsel, as well as an external lawyer. Among other things, he was responsible for several drug studies, including international WHO Phase III studies. He is an expert in pharmaceutical law, in particular also in drug studies (CRO contracts, investigator's contracts), research contracts, law of advertising and promotion of medicinal products, as well as for in- and out-licensing. Therefore he is familiar with the specific legal requirements for pharmaceutical and biotech companies.


Bernhard Schmeilzl studied at the University of Regensburg Law School (Germany) and the University of Leicester (England), both German law exams in Bavaria, graduated with distinction. Master of Laws degree (LL.M.) in European Commerce Law, graduated with distinction. Employed for three years as associate lawyer with the international law firm BBLP Beiten Burkhardt Mittl & Wegener in Munich (practice group corporate law). General legal counsel to a number of German companies, including pharmaceutical and biotech firms. Co-founder of Graf & Partners LLP in 2003 and the firm’s managing partner ever since.